Literature DB >> 2067846

Differential expression of p62c-yes in normal, hyperplastic and neoplastic human epidermis.

J Krueger1, Y H Zhao, D Murphy, M Sudol.   

Abstract

The protein product of the c-yes proto-oncogene, p62c-yes, is highly expressed in a variety of mammalian cell types, including neurons, spermatozoa, platelets, and epithelial cells. In order to understand the function of p62c-yes in epithelial cells, the expression and localization of p62c-yes was studied in cultured human epidermal keratinocytes and in normal, hyperplastic, and neoplastic human epidermis. Human keratinocytes in culture produce a single 4kb c-yes mRNA and a 62kd protein product, p62c-yes, which is active as a protein tyrosine kinase. Using affinity-purified antibodies generated to the amino-terminus of the human c-yes protein, the expression of p62c-yes was localized to keratinocytes in the basal epidermal layer of normal neonatal and adult epidermis. There was a marked reduction in expression of p62c-yes by suprabasal keratinocytes undergoing progressive differentiation. By immunofluorescence microscopy, p62c-yes was localized to the plasma membrane and to a perinuclear cytoplasmic area in cultured keratinocytes. The apparent association of p62c-yes with plasma membranes was particularly evident in suprabasal keratinocytes from hyperplastic epidermis. Neoplastic keratinocytes in basal cell carcinomas showed a marked reduction in p62c-yes expression compared to normal basal keratinocytes in epidermis or to proliferating cultured keratinocytes. Thus the expression of p62c-yes by one epithelial cell type, the keratinocyte, is altered by cellular differentiation and neoplastic transformation. Keratinocytes provide a normal epithelial cell model in which the biochemical function of p62c-yes can be studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2067846

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Functional roles for fatty acylated amino-terminal domains in subcellular localization.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts.

Authors:  D W Owens; G W McLean; A W Wyke; C Paraskeva; E K Parkinson; M C Frame; V G Brunton
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

4.  Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.

Authors:  Chunmin Yang; Afsar Alam; Fahad A Alhumaydhi; Mohd Shahnawaz Khan; Suliman A Alsagaby; Waleed Al Abdulmonem; Md Imtaiyaz Hassan; Anas Shamsi; Bilqees Bano; Dharmendra Kumar Yadav
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

5.  Increased tyrosine kinase activity of c-Src during calcium-induced keratinocyte differentiation.

Authors:  Y Zhao; M Sudol; H Hanafusa; J Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  Inactivation of c-Yes tyrosine kinase by elevation of intracellular calcium levels.

Authors:  Y Zhao; H Uyttendaele; J G Krueger; M Sudol; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.